The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 8037 -8046
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900515

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Zhou, Y.
Right arrow Articles by Blackburn, M. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y.
Right arrow Articles by Blackburn, M. R.

Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor1

Yang Zhou*, Amir Mohsenin*, Eva Morschl*, Hays W. J. Young*, Jose G. Molina*, Wenbin Ma{dagger}, Chun-Xiao Sun*, Hector Martinez-Valdez{dagger} and Michael R. Blackburn2,*

* Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, Houston, TX 77030; and {dagger} Department of Immunology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030

Adenosine is a signaling nucleoside that is generated in response to cellular injury and orchestrates the balance between tissue protection and the progression to pathological tissue remodeling. Adenosine deaminase (ADA)-deficient mice develop progressive airway inflammation and remodeling in association with adenosine elevations, suggesting that adenosine can promote features of chronic lung disease. Furthermore, pharmacological studies in ADA-deficient mice demonstrate that A2BR antagonism can attenuate features of chronic lung disease, implicating this receptor in the progression of chronic lung disease. This study examines the contribution of A2BR signaling in this model by generating ADA/A2BR double-knockout mice. Our hypothesis was that genetic removal of the A2BR from ADA-deficient mice would lead to diminished pulmonary inflammation and damage. Unexpectedly, ADA/A2BR double-knockout mice exhibited enhanced pulmonary inflammation and airway destruction. Marked loss of pulmonary barrier function and excessive airway neutrophilia are thought to contribute to the enhanced tissue damage observed. These findings support an important protective role for A2BR signaling during acute stages of lung disease.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants AI43572 and HL70952 to M.R.B. W.M. was supported by an Odyssey Program Fellowship and The Cockrell Foundation Award for Scientific Achievement at M. D. Anderson Cancer Center.

2 Address correspondence and reprint requests to Dr. Michael R. Blackburn, Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, Houston, TX. E-mail address: michael.r.blackburn{at}uth.tmc.edu

3 Abbreviations used in this paper: ADA, adenosine deaminase; AR, adenosine receptor; PEG-ADA, polyethelene glycol-ADA; BAL, bronchial alveolar lavage; PAS, periodic acid-Schiff.




This article has been cited by other articles:


Home page
PhysiologyHome page
T. Eckle, M. Koeppen, and H. K. Eltzschig
Role of Extracellular Adenosine in Acute Lung Injury
Physiology, October 1, 2009; 24(5): 298 - 306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.